Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis
- PMID: 32599467
- DOI: 10.1016/j.msard.2020.102303
Dysregulation of microRNAs regulating survivin in CD4+ T cells in multiple sclerosis
Abstract
Background: Impaired elimination mechanisms of the autoreactive lymphocytes, like T lymphocytes, via apoptosis may be the cause of continues inflammatory state in multiple sclerosis (MS). BIRC5 gene codify for the survivin, which participates in the modulation of apoptosis and cell survival. The objective of this study was investigation of the role of important confirmed miRNAs, including miR-335, miR-485, miR-542, and miR-708, in the regulation of survivin mRNA in the CD4+ T cells of MS cases.
Methods: In this study, 50 RRMS patients as well as 50 healthy matched controls were recruited. The peripheral blood mononuclear cells (PBMCs) were isolated from whole blood samples and CD4+ T cells were prepared. After that, RNA was extracted, cDNA was synthesized, and the expression levels of miR-335, miR-485, miR-542, and miR-708 were measured using Real-time PCR. Moreover, the mRNA expression of survivin was detected. Serum level of survivin was detected using ELISA.
Results: The mRNA of survivin was 2-folds upregulated in the CD4+ T cells from MS patients in comparison to the healthy controls (P = 0.0053). Serum level of survivin was higher in patients than controls. There was statistically significant downregulation of miR-485 (P = 0.001) and miR-708 (P = 0.011) in CD4+ T cells of patients compared with controls. The miR-485 downregulation had statistically significant correlation with the mRNA expression and serum level of survivin.
Conclusion: miRNAs play a role in the regulation of survivin, and therefore apoptosis of CD4+ T cells, and hence are probably participating in a persistent inflammatory condition in MS patients.
Keywords: Apoptosis; Birc5 gene; Microrna; Multiple sclerosis; Survivin.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.Front Immunol. 2022 Mar 3;13:839945. doi: 10.3389/fimmu.2022.839945. eCollection 2022. Front Immunol. 2022. Retraction in: Front Immunol. 2023 Sep 04;14:1285591. doi: 10.3389/fimmu.2023.1285591. PMID: 35309327 Free PMC article. Retracted. Review.
-
microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients.Mod Rheumatol. 2020 Sep;30(5):862-869. doi: 10.1080/14397595.2019.1659545. Epub 2019 Sep 17. Mod Rheumatol. 2020. PMID: 31441344
-
Genetic polymorphisms and epigenetic regulation of survivin encoding gene, BIRC5, in multiple sclerosis patients.BMC Immunol. 2019 Aug 22;20(1):30. doi: 10.1186/s12865-019-0312-1. BMC Immunol. 2019. PMID: 31438837 Free PMC article.
-
microRNA involvement in the regulation of survivin in peripheral blood mononuclear cells from rheumatoid arthritis patients.Int J Rheum Dis. 2019 Jun;22(6):1107-1114. doi: 10.1111/1756-185X.13520. Epub 2019 Mar 5. Int J Rheum Dis. 2019. PMID: 30834699
-
Expression, regulation and function of microRNAs in multiple sclerosis.Int J Med Sci. 2014 Jun 2;11(8):810-8. doi: 10.7150/ijms.8647. eCollection 2014. Int J Med Sci. 2014. PMID: 24936144 Free PMC article. Review.
Cited by
-
New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model.Cancer Immunol Immunother. 2024 May 2;73(6):112. doi: 10.1007/s00262-024-03684-8. Cancer Immunol Immunother. 2024. PMID: 38693422 Free PMC article.
-
MicroRNA-372 acts as a double-edged sword in human cancers.Heliyon. 2023 May 9;9(5):e15991. doi: 10.1016/j.heliyon.2023.e15991. eCollection 2023 May. Heliyon. 2023. PMID: 37251909 Free PMC article. Review.
-
Polyamines from myeloid-derived suppressor cells promote Th17 polarization and disease progression.Mol Ther. 2023 Feb 1;31(2):569-584. doi: 10.1016/j.ymthe.2022.10.013. Epub 2022 Oct 28. Mol Ther. 2023. PMID: 36307990 Free PMC article.
-
Risk Factors from Pregnancy to Adulthood in Multiple Sclerosis Outcome.Int J Mol Sci. 2022 Jun 25;23(13):7080. doi: 10.3390/ijms23137080. Int J Mol Sci. 2022. PMID: 35806081 Free PMC article. Review.
-
Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies.Front Immunol. 2022 Mar 3;13:839945. doi: 10.3389/fimmu.2022.839945. eCollection 2022. Front Immunol. 2022. Retraction in: Front Immunol. 2023 Sep 04;14:1285591. doi: 10.3389/fimmu.2023.1285591. PMID: 35309327 Free PMC article. Retracted. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials